Preventing depression and suicide in adolescents in special schools
Strong Teens and Resilient Minds: School-based Depression and Suicide Prevention in Adolescents Attending Special Schools
This study is testing a new program to help prevent depression and suicide in teenagers at special education schools in the Netherlands.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 236 (estimated) |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Sponsor | Ggz Oost Brabant Academic / other |
| Locations | 1 site (Boekel, Noordoost Brabant) |
| Trial ID | NCT06203899 on ClinicalTrials.gov |
What this trial studies
This study focuses on addressing depressive symptoms in adolescents attending special education schools in the Netherlands. It aims to screen these students for depression and implement a tailored prevention program to reduce the onset or continuation of depressive symptoms. The approach includes a randomized controlled trial comparing two conditions: the Op Volle Kracht program and Gatekeeper training. The effectiveness of these interventions will be evaluated to determine their impact on mental health outcomes in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 14 or 15 in their second or third year of secondary education who exhibit elevated depressive symptoms.
Not a fit: Patients who are clinically depressed, already receiving treatment for depression, or lack parental permission will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce depressive symptoms and the risk of suicide among adolescents in special education.
How similar studies have performed: Previous studies have shown success with school-based prevention programs for depression, indicating potential for this adapted approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents are in their second or third year of secondary education, ór adolescents will reach the age 14 or 15 in this academic year. * Score above cut-off on depression symptom questionnaire (≥ 14 on the CDI-2; Bodden et al. (2016)). Exclusion Criteria: * Adolescents who score 2 on item 8 of the CDI-2 or ≥ 23 on the VOZZ-screen (Kerkhof et al., 2015). * Clinical depression based on the clinical interview at baseline ADIS-C (Silverman \& Albano, 1996). * Absence of parental permission. * Adolescent already receiving treatment for depressive symptomatology. * Insufficient knowledge of the Dutch language.
Where this trial is running
Boekel, Noordoost Brabant
- GGZ Oost Brabant — Boekel, Noordoost Brabant, Netherlands (Recruiting)
Study contacts
- Principal investigator: Wendy CH Rongen, MSc — Ggz Oost Brabant
- Study coordinator: Wendy CH Rongen, MSc
- Email: WCH.Rongen@ggzoostbrabant.nl
- Phone: +31888461968
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.